Showing results (11-20 of 64) with videos related to
Sort By:
Pageof 7
Cancer Causes & Control : CCC|April 19, 2025
de novo metastases in patients with primary colorectal cancer: a Surveillance, Epidemiology, and End Results analysisNicole C Loroña, Kamya Sankar, Mariana C Stern, et al.Methods in Molecular Biology (Clifton, N.J.)|March 5, 2014
In vitro analysis of RNA degradation catalyzed by deadenylase enzymesJoel Hrit, Nathan Raynard, Jamie Van Etten, et al.Advances in Therapy|November 12, 2025
Real-World Treatment Patterns and Clinical Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy and ≥ 2 Subsequent Lines of Therapy in the United StatesKamya Sankar, Sudhir Unni, Marian Eberl, et al.International Journal of Radiation Oncology, Biology, Physics|February 4, 2022
Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung CancerAlex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.International Journal of Radiation Oncology, Biology, Physics|April 22, 2022
Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant DurvalumabAlex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.Plos One|May 9, 2024
How do host population dynamics impact Lyme disease risk dynamics in theoretical models?Joseph D T Savage, Christopher M MooreWorld Journal of Hepatology|May 30, 2013
Cirrhotic ascites review: Pathophysiology, diagnosis and managementChristopher M Moore, David H Van ThielInternational Journal of Molecular Sciences|April 28, 2023
Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular CarcinomaJun Ho Ji, Sang Yun Ha, Danbi Lee, et al.Lung Cancer (Amsterdam, Netherlands)|December 13, 2021
Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancerAlex K Bryant, Kamya Sankar, Garth W Strohbehn, et al.Case Reports in Hepatology|July 2, 2020
A Case of Drug-Induced Liver Injury Secondary to NatalizumabPhillip P Santoiemma, Haripriya Maddur, Christopher M MoorePageof 7